127654-03-9
| 中文名称 | 127654-03-9 |
|---|---|
| 中文同义词 | 化合物 T11755 |
| 英文名称 | KF 13218 |
| 英文同义词 | KF 13218;Hexanoic acid, 6-(5,6-dihydro-6-methyl-5-oxo-11H-pyrido[4,3-c][1]benzazepin-11-ylidene)-, (6Z)- |
| CAS号 | 127654-03-9 |
| 分子式 | C20H20N2O3 |
| 分子量 | 336.38 |
| EINECS号 | |
| 相关类别 | 对照品 |
| Mol文件 | 127654-03-9.mol |
| 结构式 |  |
127654-03-9 性质
| 沸点 | 576.2±50.0 °C(Predicted) |
|---|---|
| 密度 | 1.281±0.06 g/cm3(Predicted) |
| 储存条件 | Store at -20°C |
| 溶解度 | 溶于二甲基亚砜 |
| 酸度系数(pKa) | 4.71±0.10(Predicted) |
|
TXB 2 5.3 nM (IC 50 ) |
KF 13218 inhibits human and bovine platelet thromboxane synthase with IC 50 values of 27±5.8 nM (mean±S.E.M.) and 36±6.9 nM, respectively. KF 13218 does not inhibit cyclooxygenase or 5-lipoxygenase up to a dose of 100 μM and does not antagonize thromboxane A2/prostaglandin H2 receptors. KF 13218 inhibits arachidonic acid-induced thromboxane B2 production by human intact platelets with an IC 50 value of 5.3±1.3 nM. The IC 50 value of KF 13218 for the intact platelets is about 5 times lower than that for the microsomal enzyme. The inhibition of thromboxane synthase in platelets by KF 13218 is sustained after removal of the extracellular compound.
After oral dosing in rat from 0.03 mg/kg to 3 mg/kg, KF 13218 dose-dependently inhibits the thromboxane B2 production in serum, and the inhibition is retained for 72 h. KF 13218, at a dose of 0.1 mg/kg p.o. prevents mortality induced by sodium arachidonate in rabbit.